Your session is about to expire
← Back to Search
Sulfur Donor
UW (perfusion solution) + sodium thiosulfate (STS) for Kidney Failure
Phase 1
Waitlist Available
Led By Alp Sener, Dr.
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group
Summary
This trial will determine if thiosulfate improves kidney function in recipients of deceased donor kidneys.
Eligible Conditions
- Kidney Failure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Patient urine output
Patient urine output
Serum Creatinine
+2 moreSecondary study objectives
Biopsy proven Acute tubular necrosis (ATN)
Urinary injury biomarkers (KIM-1/NGAL).
Urine protein/creatinine ratio
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: UW (perfusion solution) + sodium thiosulfate (STS)Active Control1 Intervention
We will flush the deceased donor kidney with UW (perfusion solution) + sodium thiosulfate (STS)
Group II: UW (perfusion solution)Active Control1 Intervention
Kidney will be flushed with UW (perfusion solution) which is the normal standard of care.
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
676 Previous Clinical Trials
416,625 Total Patients Enrolled
2 Trials studying Kidney Failure
41 Patients Enrolled for Kidney Failure
Alp Sener, Dr.Principal InvestigatorLHSC
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have an allergy to sulfites.You recently received a kidney transplant from a living donor.
Research Study Groups:
This trial has the following groups:- Group 1: UW (perfusion solution) + sodium thiosulfate (STS)
- Group 2: UW (perfusion solution)
Awards:
This trial has 2 awards, including:- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger